From: Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Stage
Test result
Normal
CIN 1
CIN 2,3
CC I
CC II-IV
P1-2
0.31
0.1
0.04
0.01
0
P3
0.621
0.45
0.48
P4-5
0.069
0.95
1